Fabino Enterprises Ltd
Fabino Enterprises Ltd (FABINOLTD): company summary
Fabino Enterprises Ltd (FABINOLTD) is a micro-cap Healthcare company valued at ₹4 crore operating in Pharmaceuticals on the NSE and BSE.
Fabino Enterprises Ltd (FABINOLTD) is a micro-cap Healthcare company valued at ₹4 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 83.7% a year over three years. Return on equity is -14.3%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 1.17 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5) and valuation (6.0), but held back by quality (1.5). Growth looks strong at 7.5, but that is offset by quality at 1.5. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Low confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Revenue compounding 84% a year
- Loss-making — no meaningful P/E
- Quality is weak (1.5/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Fabino Enterprises Ltd’s valuation
Free deep-dive tools · no sign-up
Fabino Enterprises Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Fabino Enterprises Ltd with peers
Related tools & concepts
Value Fabino Enterprises Ltd with the ratios and calculators DocStoX uses in its analysis.

